Overview of D0191801 Prandial Oral Insulin 

Current oral insulin developments are focused on basal insulin, D0191801 has the potential to be the first prandial oral insulin, it offers several advantages for overall glycemic control.

D0191801 Mimics Natural Insulin Action Profile 

 

Natural Insulin Secretion Pathway 

Injected Insulin Pathway in Diabetic Patients 

D0191801 Mimics Natural Insulin Secretion Pathway